Pazopanib- 13 C,d 3 hydrochloride

Overview

Pazopanib- 13 C,d 3 (hydrochloride) is the deuterium and 13 C labeled Pazopanib hydrochloride. Pazopanib Hydrochloride (GW786034 Hydrochloride) is a novel multi-target inhibitor of VEGFR1, VEGFR2, VEGFR3, PDGFRβ , c-Kit , FGFR1, and c-Fms with an IC 50 of 10, 30, 47, 84, 74, 140 and 146 nM, respectively.

Application

Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Signaling Pathways > Autophagy | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > VEGFR | Products > Signaling Pathways > PDGFR | Products > Signaling Pathways > Autophagy | Products > Signaling Pathways > c-Fms | Products > Signaling Pathways > FGFR | Products > Signaling Pathways > c-Kit

Product Information

• Catalog No.: HY-12009S
• CAS No.: 1261398-44-0
• Molecular Formula: C2013CH21D3ClN7O2S
• Molecular Weight: 477.99
• Purity: 97.51%
• Storage: -20°C, sealed storage, away from moisture * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
• Availability: In-stock

Source

Original product source